University of Chicago Medical Center — Chicago, Illinois

Public research footprint of University of Chicago Medical Center, compiled from the ClinicalTrials.gov public registry.

846

Registered studies

285

Active

161

Recruiting now

377

Completed

165

Stopped or withdrawn

Most-studied conditions

Resectable Non-Small-Cell Lung Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · Relapsed/Refractory Multiple Myeloma · Depressive Disorder, Major

Recently updated registry entries

NCT03394365 — A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… (Recruiting)
NCT07071519 — A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… (Recruiting)
NCT06559306 — Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Chicago Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.